🔎 Trials Near Me

Akèy › Leksemi biphenotipik egi › Lwizyàn › New Orleans

Etid klinik pou Leksemi biphenotipik egi nan New Orleans, LA

3 etid pou Leksemi biphenotipik egi ap chèche patisipan nan sit nan ak bò kote New Orleans (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Ap rekriteFaz 2
  • Children's Hospital New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
365 Days · Tout sèks · Mizajou Sep 25, 2026 · NCT06317662

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Ap rekriteFaz 3
  • Children's Hospital New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
365 Days – 25 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT03959085

Etid Leksemi biphenotipik egi nan lòt vil

Lòt etid nan New Orleans

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.